Cardiac Dysfunction Among Breast Cancer Survivors: Role of Cardiotoxic Therapy and Cardiovascular Risk Factors.

Geoffrey BostanyYanjun ChenLiton FranciscoChen DaiQingrui MengJessica SparksMin SessionsLisle M Nabell Erica M Stringer-Reasor Katia KhouryCarrie LennemanKimberly Keene Saro H Armenian Wendy Landier Smita Bhatia

Published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)

These findings provide evidence to support echocardiographic surveillance for several years after cardiotoxic therapy and also suggest a need to examine the efficacy of management of cardiovascular risk factors to mitigate risk.

Keyphrases

cardiovascular risk factors
cardiovascular disease
metabolic syndrome
left ventricular
public health
oxidative stress
pulmonary hypertension
type diabetes
stem cells
left atrial
cell therapy
mesenchymal stem cells
ejection fraction